ÂÜÀòÂÒÂ×

André Choulika, Ph.D., is one of the founders of Cellectis and served as Chief Executive Officer since the company's inception in 1999. He served as Chairman of the Board of Directors from 2011 to November 2020 and President of Calyxt from August 2010 to July 2020. From 1997 to 1999, Dr. Choulika worked as a post-doctoral fellow in the Division of Molecular Medicine at Boston Children’s Hospital, where he was one of the inventors of nuclease-based genome editing technologies and a pioneer in the analysis and use of meganucleases to modify complex genomes. After receiving his Ph.D. in molecular virology from the University of Paris VI (Pierre et Marie Curie), he completed a research fellowship in the Harvard Medical School Department of Genetics. His management training is from the HEC (Challenge +). In June 2019, Dr. Choulika was appointed to the Board of Directors of the Institut Pasteur.

André Choulika was recently awarded Chevalier of the Légion d'Honneur in France.